This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Keryx Biopharmaceuticals Inc (KERX)

: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 200.29M 74.28M 55.70M 14.68M
Receivables 4.29M 882.00K 0.00 0.00
Inventories 41.88M 7.83M 0.00 0.00
Other Current Assets 2.83M 4.09M 1.23M 430.00K
Total Current Assets 249.29M 98.60M 56.93M 15.11M
Property, Plant & Equipment, Gross 5.54M 2.71M 1.23M 879.00K
Accumulated Depreciation & Depletion 452.00K 1.18M 877.00K 823.00K
Property, Plant & Equipment, Net 5.08M 1.53M 349.00K 56.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.10M 292.00K 281.00K 198.00K
Total Non-Current Assets 9.39M 5.03M 3.84M 3.46M
Liabilities & Shareholder Equity
Total Assets 258.69M 103.63M 60.77M 18.57M
Accounts Payable 21.32M 24.15M 14.00M 7.21M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 47.28M 0.00 0.00 0.00
Total Current Liabilities 77.61M 29.31M 15.33M 8.04M
Long Term Debt 90.77M 0.00 0.00 0.00
Deferred Income Taxes 790.00K 700.00K 0.00 0.00
Other Non-Current Liabilities 2.58M 133.00K 38.00K 36.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 94.14M 833.00K 38.00K 36.00K
Total Liabilities 171.75M 30.14M 15.37M 8.07M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 86.93M 73.48M 45.40M 10.49M
Common Par 105.00K 93.00K 83.00K 72.00K
Additional Paid In Capital 761.19M 624.61M 485.01M 403.39M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -674.00M -550.86M -439.34M -392.61M
Treasury Stock -357.00K -357.00K -357.00K -357.00K
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 177.71M 73.48M 45.40M 10.49M
Total Equity 86.93M 73.48M 45.40M 10.49M
Total Liabilities & Stock Equity 258.69M 103.63M 60.77M 18.57M
Total Common Shares Outstanding 105.14M 92.68M 82.64M 71.92M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 79.95K 79.95K 79.95K 79.95K
Basic Weighted Shares Outstanding 103.90M 91.00M 81.01M 71.63M
Diluted Weighted Shares Outstanding 103.90M 91.00M 81.01M 71.63M
Number of Employees 184 155 41 25
Number of Part-Time Employees 0 0 0 0
KERX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

KERX Keryx Biopharmaceuticals Inc

Chart of KERX

Analysts Ratings for KERX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 5 6
Moderate Buy 1 1 1 0
Hold 2 2 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET KERX ANALYST REPORT

KERX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs